IL1B and neoplasm: In particular, IL1β, besides its function as key element in inflammation, has a pivotal role in inducing a slow glioma-initiating cell (GIC) transition into a mesenchymal (MES) state (reactive-astrocyte-like cell state), influencing the tumor response to therapy, as well as the development of resistant tumor clones with a peculiar DNA methylation profile (21).